A pilot study of quetiapine treatment of aggression due to traumatic brain injury

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 18, Issue 4, 2006, Pages 547-549

  Kim, Edward ^a,b   Bijlani, Mona ^b  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

QUETIAPINE;

ADULT; AGGRESSION; AKATHISIA; ARTICLE; BEHAVIOR DISORDER; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; COGNITION; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; IRRITABILITY; MALE; OPEN STUDY; OUTCOME ASSESSMENT; OVERT AGGRESSION SCALE MODIFIED; PILOT STUDY; PRIORITY JOURNAL; RATING SCALE; SEDATION; SIDE EFFECT; TITRIMETRY; TRAUMATIC BRAIN INJURY; TREATMENT DURATION;

EID: 33750814945     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.2006.18.4.547     Document Type: Article

References (24)

1. Kraus JF, McArthur DL: Incidence and prevalence of, and costs associated with, traumatic brain injury, in Rehabilitation of the Adult and Child with Traumatic Brain Injury, 3rd ed. Edited by Rosenthal M, Griffith ER, Kreutzer JS, et al. Philadelphia, FA Davis Company, 1999, pp 3-18
2. Silver JM, Yudofsky SC, Anderson KE: Aggressive disorders, in Textbook of Traumatic Brain Injury. Edited by Silver JM, McAllister TW, Yudofsky SC. Washington, DC, American Psychiatric Publishing, 2005, pp 259-277
3. Alderman N, Knight C, Henman C: Aggressive behaviour observed within a neurobehavioural rehabilitation service: utility of the OAS-MNR in clinical audit and applied research. Brain Inj 2002; 16:469-189
4. Volavka J, Czobor P, Nolan K, et al: Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol. J Clin Psychopharmacol 2004; 24:225-228
5. Scharre DW, Chang SI: Cognitive and behavioral effects of quetiapine in Alzheimer disease patients. Alzheimer Dis Assoc Disord 2002; 16:128-130
6. Walker C, Thomas J, Allen TS: Treating impulsivity, irritability, and aggression of antisocial personality disorder with quetiapine. Int J Offender Ther Comp Criminol 2003; 47:556-567
7. Yudofsky SC, Silver JM, Jackson W, et al: The overt aggression scale for the objective rating of verbal and physical aggression. Am J Psychiatry 1986; 143:35-39
8. Kreutzer J, Seel R, Marwitz J: Neurobehavioral Functioning Inventory. San Antonio, Harcourt Assessment, 1999
9. Randolph C: RBANS: Repeatable Battery for the Assessment of Neuropsychological Status. San Antonio, Harcourt Assessment, 1998
10. Sandel ME, Olive DA, Rader MA: Chlorpromazine-induced psychosis after brain injury. Brain Inj 1993; 7:77-83
11. Rao N, Jellinek HM, Woolston DC: Agitation in closed head injury: haloperidol effects on rehabilitation outcome. Arch Phys Med Rehabil 1985; 66:30-34
12. Stanislav SW: Cognitive effects of antipsychotic agents in persons with traumatic brain injury. Brain Inj 1997; 11:335-341
13. Corson AH, Barkenbus JE, Posey DJ, et al: A retrospective analysis of quetiapine in the treatment of pervasive developmental disorders. J Clin Psychiatry 2004; 65:1531-1536
14. Schreiber S, Klag E, Gross Y, et al: Beneficial effect of risperidone on sleep disturbance and psychosis following traumatic brain injury. Int Clin Psychopharmacol 1998; 13:273-275
15. Burke JG, Dursun SM, Reveley MA: Refractory symptomatic schizophrenia resulting from frontal lobe lesion: response to clozapine. J Psychiatry Neurosci 1999; 24:456-461
16. Temple MJ: Use of atypical anti-psychotics in the management of post-traumatic confusional states in traumatic brain injury. J R Army Med Corps 2003; 149:54-55
17. Krieger D, Hansen K, McDermott C, et al: Loxapine versus olanzapine in the treatment of delirium following traumatic brain injury. Neurorehabilitation 2003; 18:205-208
18. Bilder RM, Goldman RS, Volavka J, et al: Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry 2002; 159:1018-1028
19. Harvey PD, Meltzer H, Simpson GM, et al: Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia. Schizophr Res 2004; 66:101-113
20. Kivircik Akdede BB, Alptekin K, et al: Effects of quetiapine on cognitive functions in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29:233-238
21. Eysenck MW: Anxiety and cognitive functioning: a multifaceted approach, in Perspectives of Cognitive Neurosciences. Edited by Lister RG, Weingartner HJ. New York, Oxford University Press, 1991
22. Massman PJ, Delis DC, Butters N, et al: The subcortical dysfunction hypothesis of memory deficits in depression: neuropsychological validation in a subgroup of patients. J Clin Exp Neuropsychol 1992; 14:687-706
23. Quemada JI, Munoz Cespedes JM, Ezkerra J, et al: Outcome of memory rehabilitation in traumatic brain injury assessed by neuropsychological tests and questionnaires. J Head Trauma Rehabil 2003; 18:532-540
24. Leahy BJ, Lam CS: Neuropsychological testing and functional outcome for individuals with traumatic brain injury. Brain Inj 1998; 12:1025-1035